ASST
Strive, Inc.
There isn't enough reported data to score ASST yet.
TMUS
T-Mobile US, Inc.
TMUS's fundamentals are mixed, but it looks cheap: trading at 16x earnings, below its usual 27x. Analysts expect strong earnings growth.
ASST Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Strong |
ASST's revenue and balance sheet are currently healthy, but its profitability and cash flow are weak.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ASST PE Valuation
ASST has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 6.0x next year's earnings.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
ASST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASST to return to profit, with revenue growing. However, they disagree widely on these estimates.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TMUS, with profitability improving.
ASST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.73 | — |
| Q3 2026 | -$183.86 | -$41.36 |
| Q2 2026 | -$313.10 | -$286.40 |
| Q1 2026 | -$312.73 | -$277.83 |
| Q4 2025 | -$310.80 | -$242.50 |
| Q3 2025 | -$142.50 | -$78.70 |
| Q2 2025 | -$26.70 | +$37.90 |
| Q1 2025 | -$34.90 | +$28.10 |
| Q4 2024 | -$68.30 | -$32.30 |
ASST lost $183.86 per share over the past year, a bigger loss than the year before.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the edge over ASST on earnings quality, reporting a profit while its opponent remains loss making.
ASST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +75% |
| Q2 2026 | $2.9M | +1597% |
| Q1 2026 | $2.8M | +1516% |
| Q4 2025 | $1.5M | +611% |
| Q3 2025 | $1.5M | +660% |
| Q2 2025 | $173.3K | +86% |
| Q1 2025 | $170.7K | +37% |
| Q4 2024 | $212.8K | +163% |
ASST has the edge over TMUS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18844% | +20355 points |
| Q2 2026 | -8781% | -7227 points |
| Q1 2026 | -11346% | -10376 points |
| Q4 2025 | -15948% | -15020 points |
| Q3 2025 | -1511% | -863 points |
| Q2 2025 | -1554% | +303 points |
| Q1 2025 | -970% | +141 points |
| Q4 2024 | -928% | +739 points |
ASST has the edge over TMUS on profitability, with a higher operating margin.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS's revenue has grown year over year for 10 quarters in a row: $23.6B last quarter, up 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS's operating margin was 24% last quarter, up 3.4 points from the same quarter a year ago.
ASST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.1M | +$18.8M |
| Q3 2025 | -$28.9M | -$27.8M |
| Q2 2024 | -$1.3M | -$146.2K |
| Q1 2024 | -$1.1M | -$224.6K |
| Q4 2023 | -$860.1K | -$650.5K |
| Q2 2023 | -$1.1M | -$917.5K |
| Q1 2023 | -$829.9K | -$754.9K |
| Q4 2022 | -$209.6K | -5434% |
ASST has burned cash in almost every quarter: −$75M over the past year, against −$32M the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over ASST on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASST Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +20% | +15.3M shares |
| 1 year | +5331% | +88.9M shares |
| 3 years | +65691% | +90.4M shares |
| 5 years | +1478019% | +90.5M shares |
ASST has 91M diluted shares, up 5331% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | $500,000 |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over ASST on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
ASST Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -1.7x | Net Cash |
ASST has more cash than debt.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
ASST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 51.4 | Neutral |
ASST's weekly RSI is 51 (neutral) and its Stochastic is 51 (neutral).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
ASST PE vs Communication Services Sector
ASST has no meaningful PE right now: it lost money over the past year.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
ASST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.8 | 14% below |
| 20 week MA | $20.8 | 7% above |
| 50 week MA | $16.8 | 32% above |
| 100 week MA | $35.7 | 38% below |
ASST has stronger trend alignment. ASST is above 2 of 4 weekly averages versus TMUS above 1 of 5.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.
ASST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $355.0 | $63.9 | -82% |
| 2024 | $63.9 | $9.32 | -85% |
| 2025 | $9.32 | $16.3 | +75% |
| 2026 YTD | $16.3 | $22.3 | +37% |
ASST has the edge over TMUS on returns for 2026, with the stronger performance.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has finished higher in four of the last six years. It's down 15% so far in 2026.